The mRVG-9R peptide as a potential therapeutic vector to the central nervous system cellsCELL BIOLOGY INTERNATIONALIF3.12019-05-217PREAI
Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathwaysNEUROBIOLOGY OF DISEASEIF5.62015-09-0162OAAI
Alterations in Energy/Redox Metabolism Induced by Mitochondrial and Environmental Toxins: A Specific Role for Glucose-6-Phosphate-Dehydrogenase and the Pentose Phosphate Pathway in Paraquat ToxicityACS CHEMICAL BIOLOGYIF3.82014-07-0780OAAI
Antioxidant gene therapy against neuronal cell deathPHARMACOLOGY & THERAPEUTICSIF12.52014-05-01122OAAI
Glutaredoxin 1 Protects Dopaminergic Cells by Increased Protein Glutathionylation in Experimental Parkinson's DiseaseANTIOXIDANTS & REDOX SIGNALINGIF6.12012-12-1540OA
Thiol-Redox Signaling, Dopaminergic Cell Death, and Parkinson's DiseaseANTIOXIDANTS & REDOX SIGNALINGIF6.12012-12-1581OA
Distinct Role of Glutaredoxin 1 and 2 Regulating Protein Glutathionylation and Dopaminergic Cell DeathFREE RADICAL BIOLOGY AND MEDICINEIF8.22012-11-010PREAI
Alpha-Synuclein Impairs Autophagic Flux Increasing Oxidative Stress and Dopaminergic Cell Death Induced by Environmental Copper ExposureFREE RADICAL BIOLOGY AND MEDICINEIF8.22012-11-010PREAI
Selective Role of Cytosolic and Mitochondrial Glutathione Homeostasis in Experimental Parkinson's Disease ModelsFREE RADICAL BIOLOGY AND MEDICINEIF8.22012-11-010PREAI